The contemporary safety and effectiveness of lower extremity bypass surgery and peripheral endovascular interventions in the treatment of symptomatic peripheral arterial disease

Circulation

Volumn 132, Issue 21, 2015, Pages 1999-2011

  Tsai, Thomas T ^a,b   Rehring, Thomas F ^a,b   Rogers, R Kevin ^b   Shetterly, Susan M ^a   Wagner, Nicole M ^a   Gupta, Rajan ^b   Jazaeri, Omid ^b   Hedayati, Nasim ^c   Jones, W Schuyler ^d   Patel, Manesh R ^d   Ho, P Michael ^a,b,e   Go, Alan S ^f   Magid, David J ^a,b  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f DIVISION OF RESEARCH   (United States)

Author keywords

comparative effectiveness research; lower extremity bypass surgery; peripheral arterial disease

Indexed keywords

AGED; ARTICLE; BLOOD TRANSFUSION; BYPASS SURGERY; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CLAUDICATION; COMPARATIVE EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; DIALYSIS; EMBOLISM; ENDOVASCULAR SURGERY; FEMALE; GENERAL CONDITION DETERIORATION; GLOMERULUS FILTRATION RATE; HEALTH CARE DELIVERY; HEART MUSCLE REVASCULARIZATION; HUMAN; LEG AMPUTATION; LOWER EXTREMITY BYPASS SURGERY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PATIENT SAFETY; PERIPHERAL ENDOVASCULAR INTERVENTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPENSITY SCORE; SURGICAL INFECTION; SURGICAL MORTALITY; ADVERSE EFFECTS; AMPUTATION; CALIFORNIA; CLINICAL TRIAL; COLORADO; COMORBIDITY; EVALUATION STUDY; INCIDENCE; INTEGRATED HEALTH CARE SYSTEM; INTERMITTENT CLAUDICATION; ISCHEMIA; KAPLAN MEIER METHOD; LOWER LIMB; MIDDLE AGED; MULTICENTER STUDY; PERIPHERAL ARTERIAL DISEASE; POSTOPERATIVE COMPLICATIONS; REGISTER; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; SURGICAL WOUND INFECTION; TREATMENT OUTCOME; UTILIZATION; VASCULAR SURGERY; VASCULARIZATION;

AGED; AMPUTATION; CALIFORNIA; COLORADO; COMORBIDITY; DELIVERY OF HEALTH CARE, INTEGRATED; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; INCIDENCE; INTERMITTENT CLAUDICATION; ISCHEMIA; KAPLAN-MEIER ESTIMATE; LOWER EXTREMITY; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POSTOPERATIVE COMPLICATIONS; REGISTRIES; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 84948092140     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.013440     Document Type: Article

References (27)

1. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001; 344: 1608-1621. doi: 10.1056/NEJM200105243442108.
2. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001; 286: 1317-1324.
3. Valadares MC, Bincoletto C, Oliveira SC, de Melo A, Saad ST, Queiroz ML. Bone marrow progenitor cells from chemically exposed workers display an intrinsic ability for autonomous proliferation. Immunopharmacol Immunotoxicol. 2005; 27: 137-145. doi: 10.1081/IPH-51761.
4. Anderson PL, Gelijns A, Moskowitz A, Arons R, Gupta L, Weinberg A, Faries PL, Nowygrod R, Kent KC. Understanding trends in inpatient surgical volume: Vascular interventions, 1980-2000. J Vasc Surg. 2004; 39: 1200-1208.
5. Kakkos SK, Geroulakos G, Nicolaides AN. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial. Eur J Vasc Endovasc Surg. 2005; 30: 164-175. doi: 10.1016/j.ejvs.2005.03.011.
6. Regensteiner JG, Meyer TJ, Krupski WC, Cranford LS, Hiatt WR. Hospital vs home-based exercise rehabilitation for patients with peripheral arterial occlusive disease. Angiology. 1997; 48: 291-300.
7. Regensteiner JG. Exercise in the treatment of claudication: assessment and treatment of functional impairment. Vasc Med. 1997; 2: 238-242.
8. Regensteiner JG, Gardner A, Hiatt WR. Exercise testing and exercise rehabilitation for patients with peripheral arterial disease: status in 1997. Vasc Med. 1997; 2: 147-155.
9. Currie IC, Wilson YG, Baird RN, Lamont PM. Treatment of intermittent claudication: the impact on quality of life. Eur J Vasc Endovasc Surg. 1995; 10: 356-361.
10. Jaff MR, Cahill KE, Yu AP, Birnbaum HG, Engelhart LM. Clinical outcomes and medical care costs among Medicare beneficiaries receiving therapy for peripheral arterial disease. Ann Vasc Surg. 2010; 24: 577-587. doi: 10.1016/j.avsg.2010.03.015.
11. Nicolaï SP, Kruidenier LM, Rouwet EV, Graffius K, Prins MH, Teijink JA. The walking impairment questionnaire: an effective tool to assess the effect of treatment in patients with intermittent claudication. J Vasc Surg. 2009; 50: 89-94. doi: 10.1016/j.jvs.2008.12.073.
12. Kügler CF, Rudofsky G. Do age and comorbidity affect quality of life or PTA-induced quality-of-life improvements in patients with symptomatic pad? J Endovasc Ther. 2005; 12: 387-393. doi: 10.1583/04-1449.1.
13. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, Namini H, Hamdan AD, Roddy SP, Belkin M, Berceli SA, DeMasi RJ, Samson RH, Berman SS. PREVENT III Investigators. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006; 43: 742-751; discussion 751. doi: 10.1016/j.jvs.2005.12.058.
14. McDermott MM, Liu K, Guralnik JM, Martin GJ, Criqui MH, Greenland P. Measurement of walking endurance and walking velocity with questionnaire: validation of the walking impairment questionnaire in men and women with peripheral arterial disease. J Vasc Surg. 1998; 28: 1072-1081.
15. Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg. 1996; 23: 104-115.
16. Wullink M, Stoffers HE, Kuipers H A primary care walking exercise program for patients with intermittent claudication. Med Sci Sports Exerc. 2001; 33: 1629-1634.
17. Landry GJ. Functional outcome of critical limb ischemia. J Vasc Surg. 2007; 45 (suppl A): A141-A148. doi: 10.1016/j.jvs.2007.02.052.
18. Spertus J, Jones P, Poler S, Rocha-Singh K. The peripheral artery questionnaire: a new disease-specific health status measure for patients with peripheral arterial disease. Am Heart J. 2004; 147: 301-308. doi: 10.1016/.j.ahj.2003.08.001.
19. Kalbaugh CA, Taylor SM, Cull DL, Blackhurst DW, Gray BH, Langan EM 3rd, Dellinger MB, McClary GE Jr, Jackson MR, Carsten CG 3rd, Snyder BA, York JW, Youkey JR. Invasive treatment of chronic limb ischemia according to the Lower Extremity Grading System (LEGS) score: a 6-month report. J Vasc Surg. 2004; 39: 1268-1276. doi: 10.1016/j.jvs.2004.02.009.
20. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, Fowkes FG, Gillepsie I, Ruckley CV, Raab G, Storkey H. BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005; 366: 1925-1934. doi: 10.1016/S0140-6736(05)67704-5.
21. Mehta T, Venkata Subramaniam A, Chetter I, McCollum P. Assessing the validity and responsiveness of disease-specific quality of life instruments in intermittent claudication. Eur J Vasc Endovasc Surg. 2006; 31: 46-52. doi: 10.1016/j.ejvs.2005.08.028.
22. Wann-Hansson C, Hallberg IR, Risberg B, Lundell A, Klevsgard R. Health-related quality of life after revascularization for peripheral arterial occlusive disease: long-Term follow-up. J Adv Nurs. 2005; 51: 227-235. doi: 10.1111/j.1365-2648.2005.03499.x.
23. Martem'ianov SV, Uvarov EA, Safonova OV. Assessment of the patient's quality of life in the long-Term postoperative period after reconstructions on lower extremity arteries. Angiol Sosud Khir. 2004; 10: 129-135.
24. Brott TG, Hobson RW 2nd, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF. CREST Investigators. Stenting versus endarterectomy for treatment of carotid-Artery stenosis. N Engl J Med. 2010; 363: 11-23. doi: 10.1056/NEJMoa0912321.
25. Ringleb PA, Allenberg J, Brückmann H, Eckstein HH, Fraedrich G, Hartmann M, Hennerici M, Jansen O, Klein G, Kunze A, Marx P, Niederkorn K, Schmiedt W, Solymosi L, Stingele R, Zeumer H, Hacke W. SPACE Collaborative Group. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet. 2006; 368: 1239-1247. doi: 10.1016/S0140-6736(06)69122-8.
26. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, Larrue V, Lièvre M, Leys D, Bonneville JF, Watelet J, Pruvo JP, Albucher JF, Viguier A, Piquet P, Garnier P, Viader F, Touzé E, Giroud M, Hosseini H, Pillet JC, Favrole P, Neau JP, Ducrocq X. EVA-3S Investigators. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006; 355: 1660-1671. doi: 10.1056/NEJMoa061752.
27. Randomized placebo-controlled, double-blind trial of ketanserin in claudicants. Changes in claudication distance and ankle systolic pressure. Pack claudication substudy. Circulation. 1989; 80: 1544-1548.